文献速递神经核医学

氯氮平诱导星形胶质细胞依赖性FDG-PET低代谢

Clozapine induces astrocyte-dependent FDG-PET hypometabolism.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2022-02-05

研究以成年雄性Wistar大鼠为对象,对照组14只、氯氮平组12只,给予氯氮平(25/35 mg kg-1)6周,用FDG-PET及皮质组织、星形胶质细胞与神经元培养评估葡萄糖利用变化。结果显示氯氮平显著降低多个脑区尤其皮质的体内葡萄糖代谢,伴皮质谷氨酸转运下降及GLT-1 mRNA与蛋白下调;星形胶质细胞培养中氯氮平降低GLT-1密度及谷氨酸与葡萄糖摄取,而皮质神经元培养中氯氮平不影响葡萄糖摄取。作者认为该工作提供了GLT-1下调诱导星形胶质细胞依赖性皮质FDG-PET低代谢的体内证据,并进一步表明星形胶质细胞是FDG-PET信号的重要贡献者。

要点

  • 氯氮平(25/35 mg kg-1)6周显著降低大鼠多个脑区尤其皮质的体内FDG-PET葡萄糖代谢。
  • 氯氮平使皮质谷氨酸转运下降,并下调GLT-1 mRNA与蛋白水平。
  • 星形胶质细胞培养中氯氮平降低GLT-1密度及谷氨酸与葡萄糖摄取,皮质神经元培养中氯氮平不影响葡萄糖摄取。

核心结论

  • 该工作提供了GLT-1下调诱导星形胶质细胞依赖性皮质FDG-PET低代谢的体内证据,并进一步表明星形胶质细胞是FDG-PET信号的重要贡献者。

研究设计与样本

  • 成年雄性Wistar大鼠,对照组n=14、氯氮平组n=12,给予氯氮平(25/35 mg kg-1)6周。
  • 体内用FDG-PET评估,皮质组织评估谷氨酸摄取及GLT-1与GLAST水平。
  • 另在皮质星形胶质细胞培养(葡萄糖与谷氨酸摄取、GLT-1与GLAST水平)和皮质神经元培养(葡萄糖摄取)中评估氯氮平效应。

主要发现

  • 氯氮平显著降低体内多个脑区尤其皮质的脑葡萄糖代谢。
  • 离体分析显示皮质谷氨酸转运下降,伴GLT-1 mRNA与蛋白下调。
  • 星形胶质细胞培养中氯氮平降低GLT-1密度以及谷氨酸和葡萄糖摄取。
  • 皮质神经元培养中氯氮平不影响葡萄糖摄取。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Advances in functional imaging allowed us to visualize brain glucose metabolism in vivo and non-invasively with [18F]fluoro-2-deoxyglucose (FDG) positron emission tomography (PET) imaging. In the past decades, FDG-PET has been instrumental in the understanding of brain function in health and disease. The source of the FDG-PET signal has been attributed to neuronal uptake, with hypometabolism being considered as a direct index of neuronal dysfunction or death. However, other brain cells are also metabolically active, including astrocytes. Based on the astrocyte-neuron lactate shuttle hypothesis, the activation of the glutamate transporter 1 (GLT-1) acts as a trigger for glucose uptake by astrocytes. With this in mind, we investigated glucose utilization changes after pharmacologically downregulating GLT-1 with clozapine (CLO), an anti-psychotic drug. METHODS: Adult male Wistar rats (control, n = 14; CLO, n = 12) received CLO (25/35 mg kg-1) for 6 weeks. CLO effects were evaluated in vivo with FDG-PET and cortical tissue was used to evaluate glutamate uptake and GLT-1 and GLAST levels. CLO treatment effects were also assessed in cortical astrocyte cultures (glucose and glutamate uptake, GLT-1 and GLAST levels) and in cortical neuronal cultures (glucose uptake). RESULTS: CLO markedly reduced in vivo brain glucose metabolism in several brain areas, especially in the cortex. Ex vivo analyses demonstrated decreased cortical glutamate transport along with GLT-1 mRNA and protein downregulation. In astrocyte cultures, CLO decreased GLT-1 density as well as glutamate and glucose uptake. By contrast, in cortical neuronal cultures, CLO did not affect glucose uptake. CONCLUSION: This work provides in vivo demonstration that GLT-1 downregulation induces astrocyte-dependent cortical FDG-PET hypometabolism-mimicking the hypometabolic signature seen in people developing dementia-and adds further evidence that astrocytes are key contributors of the FDG-PET signal.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Rocha A, Bellaver B, Souza DG, et al. Clozapine induces astrocyte-dependent FDG-PET hypometabolism. Eur J Nucl Med Mol Imaging. 2022. PMID: 35122511. doi:10.1007/s00259-022-05682-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。